NEW YORK (GenomeWeb News) - Ingenuity Systems said today that a group of researchers studying neuropsychiatric disorders will use its pathway analysis software to track genetic links to certain diseases.
The Pritzker Neuropsychiatric Disorders Research Consortium will use the Ingenuity Pathway Analysis software in research aimed at understanding the genetic and biological causes of disorders such as depression, manic depression, bipolar disorder, and schizophrenia in order to identify targets for treatments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.